目的 評(píng)定LC-MS法測(cè)定人血漿中五味子醇甲的不確定度.方法 對(duì)LC-MS法測(cè)定人血漿中五味子醇甲的全過(guò)程進(jìn)行分析,建立數(shù)學(xué)模型,確定影響不確定度的因素并對(duì)各個(gè)因素進(jìn)行評(píng)估,計(jì)算合成不確定度及擴(kuò)展不確定度.結(jié)果 置信概率P為95%時(shí),血漿中低、中、高(0.61、12.26、245.20 μg/L)濃度五味子醇甲的擴(kuò)展不確定度分別為1.08、1.76、27.00 μg/L.結(jié)論 本方法適用于LC-MS法測(cè)定人血漿中五味子醇甲的不確定度評(píng)定,不確定度主要由線性回歸過(guò)程引入.

Objective To evaluate the uncertainty in determination of schisandrin in human plasma by LC-MS. Methods The uncertainty caused by various factors in the whole process of determination was analyzed. Mathematical model was established. Influential factors of uncertainty were identified and evaluated. The combined uncertainty was calculated and the expanded uncertainty was obtained. Results The expanded uncertainty for the low, medium and high levels (0.61, 12.26, and 245.20 μg/L)of schisandrin was 1.08, 1.76, and 27.00 μg/L, respectively (P = 95%). Conclusion This method is applicable to the uncertainty evaluation of schisandrin determination in human plasma, and the uncertainty of this method was mainly caused by linear regression.

國(guó)家"十二五"重大新藥創(chuàng)制項(xiàng)目:"中藥新藥臨床評(píng)價(jià)研究技術(shù)平臺(tái)"(2012ZX09303-017);國(guó)家臨床重點(diǎn)?？平ㄔO(shè)項(xiàng)目經(jīng)費(fèi)資助(2013年);國(guó)家中醫(yī)藥管理局臨床中藥學(xué)重點(diǎn)學(xué)科(2009年);遼寧中醫(yī)藥大學(xué)杏林學(xué)者青藍(lán)工程(2013年)